Angiotensin converting-enzyme inhibitor in refractory hypertension.

$Refractory hypertension.$
Refractory hypertension.

Acute effects of angiotensin-converting enzyme inhibitor on erythrocyte sodium ion transport in essential hypertension.

Angiotensin II in essential hypertension.

Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.

Angiotensin-converting enzyme inhibitor renography in the diagnosis of renovascular hypertension. Studies before and after angioplasty.

Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.

$Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.$
Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.

Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.

Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.

Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.

$When Nothing Else Works: Fresh Frozen Plasma in the Treatment of Progressive, Refractory Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.$
When Nothing Else Works: Fresh Frozen Plasma in the Treatment of Progressive, Refractory Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.

The intrarenal renin-angiotensin system in hypertension.

$Administration of angiotensin II in refractory septic shock.$
Administration of angiotensin II in refractory septic shock.

$Resistant or refractory hypertension: are they different?$
Resistant or refractory hypertension: are they different?

Angiotensin converting enzyme inhibitors and moderate hypertension.

Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.

Renal injury from angiotensin II-mediated hypertension.

Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.

Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension.

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study.

Angiotensin and neurovascular coupling: beyond hypertension.

The renin-angiotensin system and hypertension.

Angiotensin-converting enzyme inhibitor-induced angioedema.

Suggest Documents

Refractory hypertension.

Acute effects of angiotensin-converting enzyme inhibitor on erythrocyte sodium ion transport in essential hypertension.

Angiotensin II in essential hypertension.

Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.

Angiotensin-converting enzyme inhibitor renography in the diagnosis of renovascular hypertension. Studies before and after angioplasty.

Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.

Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.

Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension.

Hemodialysis-resistant hypertension: control with an orally active inhibitor of angiotensin-converting enzyme.

Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.

When Nothing Else Works: Fresh Frozen Plasma in the Treatment of Progressive, Refractory Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema.

The intrarenal renin-angiotensin system in hypertension.

Administration of angiotensin II in refractory septic shock.

Resistant or refractory hypertension: are they different?

Angiotensin converting enzyme inhibitors and moderate hypertension.

Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor.

Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.

Renal injury from angiotensin II-mediated hypertension.

Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.

Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension.

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study.

Angiotensin and neurovascular coupling: beyond hypertension.

The renin-angiotensin system and hypertension.

Angiotensin-converting enzyme inhibitor-induced angioedema.

Angiotensin converting-enzyme inhibitor in refractory hypertension.

Recommend Documents

Follow Us